cysteine has been researched along with Cardiac Diseases in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (12.50) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 7 (43.75) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Abdellatif, M; Alegre-Cebollada, J; Bonzón-Kulichenko, E; Calvo, E; Careaga, CB; Fernández-Trasancos, Á; Giganti, D; Herrero-Galán, E; Martínez-Martín, I; Pérez-Jiménez, R; Pricolo, MR; Rainer, PP; Sánchez-González, C; Sedej, S; Suay-Corredera, C; Vázquez, J; Velázquez-Carreras, D; Vicente, N | 1 |
Fonović, M; Turk, B; Vizovišek, M | 1 |
Paetzel, M; Tibbits, GF; Zhang, XL | 1 |
Bachschmid, MM; Behring, JB; Chauhan, P; Cohen, RA; Colucci, WS; Costello, CE; Kumar, V; McComb, ME; Siwik, DA; Whelan, SA | 1 |
Bachschmid, MM; Behring, JB; Cohen, RA; Colucci, WS; Costello, CE; Elezaby, A; Matsui, R; McComb, ME; Seta, F; Shao, D; Siwik, DA; Sverdlov, AL; Whelan, SA; Yao, C; Yin, X | 1 |
Avila, M; de Prost, N; El-Karak, C; Ichinose, F; Vidal Melo, MF | 1 |
Altschmied, J; Haendeler, J; Matsushima, S; Sadoshima, J; Shao, D; Zschauer, TC | 1 |
Louis, XL; Murphy, R; Netticadan, T; Thandapilly, SJ; Yu, L | 1 |
GILBERT, J; ISRAUEL-ASSELAIN, R | 1 |
Padmanabhan, M; Prince, PS | 1 |
Mainzen Prince, PS; Padmanabhan, M | 1 |
Hool, LC | 1 |
Berti, F; Buccellati, C; Folco, GC; Maclouf, J; Molta, C; Muller-Peddinghaus, R; Rossoni, G; Sala, A; Testa, T | 1 |
Kitano, T; Matsumura, K; Murashima, S; Nakagawa, T; Nakashima, H; Takeda, K; Tanaka, K; Yada, I; Yuasa, H | 1 |
Abdelmouttaleb, I; Barbé, F; Chango, A; Gérard, P; Guéant, JL; Klein, M; Lambert, D; Nicolas, JP; Quilliot, D | 1 |
Dietze, F; Lisewski, G; Reitzig, P; Schulz, HJ | 1 |
3 review(s) available for cysteine and Cardiac Diseases
Article | Year |
---|---|
Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond.
Topics: Arthritis, Rheumatoid; Cathepsins; Cysteine; Cysteine Endopeptidases; Extracellular Matrix; Heart Diseases; Humans; Inflammation; Lysosomes; Neoplasms; Proteolysis | 2019 |
Interacting with thioredoxin-1--disease or no disease?
Topics: Animals; Atherosclerosis; Blood Vessels; Cardiovascular System; Cysteine; Cystine; Diabetes Mellitus, Type 2; Heart Diseases; Humans; Hydrogen Peroxide; Mice; Models, Cardiovascular; Molecular Targeted Therapy; Myocardium; NADP; Neoplasm Proteins; Neoplasms; Oxidation-Reduction; Peroxiredoxins; Reactive Oxygen Species; Signal Transduction; Thioredoxins | 2013 |
Evidence for the regulation of L-type Ca2+ channels in the heart by reactive oxygen species: mechanism for mediating pathology.
Topics: Animals; Antioxidants; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cysteine; Heart Diseases; Humans; Hypoxia; Ion Channel Gating; Myocardium; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2008 |
1 trial(s) available for cysteine and Cardiac Diseases
Article | Year |
---|---|
[Presurgical evaluation of cerebral perfusion reserve in patients for cardiovascular surgery using 99mTc-ECD SPECT with diamox enhancement].
Topics: Acetazolamide; Aged; Aortic Aneurysm; Brain; Cerebrovascular Circulation; Cysteine; Female; Heart Diseases; Humans; Male; Middle Aged; Organotechnetium Compounds; Predictive Value of Tests; Preoperative Care; Tomography, Emission-Computed, Single-Photon | 1996 |
12 other study(ies) available for cysteine and Cardiac Diseases
Article | Year |
---|---|
Basal oxidation of conserved cysteines modulates cardiac titin stiffness and dynamics.
Topics: Animals; Connectin; Cysteine; Elasticity; Heart Diseases; Humans; Mice; Myocardium; Oxidation-Reduction; Protein Kinases; Sarcomeres | 2022 |
The structure of cardiac troponin C regulatory domain with bound Cd2+ reveals a closed conformation and unique ion coordination.
Topics: Amino Acid Motifs; Binding Sites; Cadmium; Calcium; Crystallography, X-Ray; Cysteine; Heart Diseases; Models, Molecular; Mutation; Protein Conformation; Protein Folding; Protein Structure, Tertiary; Troponin C | 2013 |
Does reversible cysteine oxidation link the Western diet to cardiac dysfunction?
Topics: Animals; Chromatography, Liquid; Citric Acid Cycle; Cysteine; Diet; Fatty Acids; Glycolysis; Heart Diseases; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Obesity; Oxidative Phosphorylation; Oxygen; Phenotype; Protein Processing, Post-Translational; Proteomics; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfhydryl Compounds; Tandem Mass Spectrometry | 2014 |
Overexpression of Catalase Diminishes Oxidative Cysteine Modifications of Cardiac Proteins.
Topics: Aging; Animals; Catalase; Cysteine; Female; Heart Diseases; Humans; Hydrogen Peroxide; Male; Mice; Mice, Transgenic; Mitochondria, Heart; Muscle Proteins; Myocardium; Oxidation-Reduction; Oxidative Stress; Protein Processing, Post-Translational; Signal Transduction | 2015 |
Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary disease.
Topics: Aged; Analysis of Variance; Biomarkers; Boston; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chi-Square Distribution; Cysteine; Enzyme-Linked Immunosorbent Assay; Heart Diseases; Humans; Inflammation Mediators; Leukotriene B4; Leukotrienes; Lung; Middle Aged; Neutrophil Activation; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Mechanics; Severity of Illness Index; Time Factors; Treatment Outcome | 2011 |
Garlic extracts prevent oxidative stress, hypertrophy and apoptosis in cardiomyocytes: a role for nitric oxide and hydrogen sulfide.
Topics: Animals; Antioxidants; Apoptosis; Cysteine; Disulfides; Garlic; Heart; Heart Diseases; Hydrogen Sulfide; Hypertrophy; Male; Myocardium; Myocytes, Cardiac; Nitric Oxide; Norepinephrine; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Sulfinic Acids | 2012 |
[TREATMENT AND PREVENTION OF CHRONIC DYSPNEIC BRONCHITIS].
Topics: Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitussive Agents; Atropine; Balneology; Bronchitis; Bronchitis, Chronic; Chymotrypsin; Climate; Cortisone; Cysteine; Dyspnea; Ephedrine; Exercise Therapy; Heart Diseases; Humans; Hydrocortisone; Hypnotics and Sedatives; Theophylline; Trypsin; Vaccination | 1964 |
Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Ascorbic Acid; Cysteine; Glutathione; Heart Diseases; Isoproterenol; Lipid Peroxides; Male; Myocardium; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Tocopherols | 2006 |
S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymes.
Topics: Adrenergic beta-Agonists; alpha-Tocopherol; Animals; Antineoplastic Agents; Cysteine; Electrocardiography; Heart Diseases; Isoproterenol; Lysosomes; Male; Mitochondria, Heart; Myocardial Infarction; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2007 |
Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes.
Topics: Animals; Arachidonate 5-Lipoxygenase; Calcimycin; Coronary Vessels; Creatine Kinase; Cysteine; Electrocardiography; Endothelium, Vascular; Enzyme Activation; Heart; Heart Diseases; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Leukotrienes; Lipoxygenase Inhibitors; Male; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Quinolines; Rabbits | 1996 |
Detection of moderate hyperhomocysteinemia: comparison of the Abbott fluorescence polarization immunoassay with the Bio-Rad and SBD-F high-performance liquid chromatographic assays.
Topics: Chemistry, Clinical; Chromatography, High Pressure Liquid; Cysteine; Diabetes Mellitus; Heart Diseases; Humans; Hyperhomocysteinemia; Hyperthyroidism; Hypothyroidism; Spectrometry, Fluorescence | 2001 |
[Malabsorption syndrome and intestinal pseudoobstruction in primary vascular and heart amyloidosis].
Topics: Adult; Amyloidosis; Antibody Formation; Antigen-Antibody Complex; Azathioprine; Chloramphenicol; Cysteine; Heart Diseases; Humans; Intestinal Obstruction; Malabsorption Syndromes; Male; Melphalan; Penicillamine; Prednisone; Time Factors; Vascular Diseases | 1973 |